Brinzolamide 1%/brimonidine 0.2% ophthalmic suspension
Sponsors
Alcon Research
Conditions
Ocular HypertensionOpen Angle GlaucomaOpen-Angle Glaucoma
Phase 4
Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®
CompletedNCT01937299
Start: 2013-10-31End: 2014-04-30Updated: 2015-05-14
Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue
CompletedNCT01937312
Start: 2013-10-31End: 2014-05-31Updated: 2015-07-28
Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension
CompletedNCT01978600
Start: 2013-10-31End: 2014-03-31Updated: 2015-04-13